IFI-M · CUS Tri-Axis Balanced Series

Specimen SS-F-M3-01870 // MULTI-AXIS · IFI-M

CUS Tri-Axis Balanced Series IV-NP

Mentha × piperita

Peppermint

Tier IVCUS Tri-Axis Balanced Series

Target Trait

2.13×

fold-change

Cooling+Umami+Sweet balanced tri-axis fold-change

Technical Specifications

SKU

SS-F-M3-01870

Genomic Edits

10

GC Content

44.8%

Construct Length

5,878 bp

Promoter System

Lipid nanoparticle / Ubiquitin

Expression System

Nanoparticle delivery

Host Strain

LNP-mediated

Receptor Target

TRPM8 + mGluR1 + TAS1R2/TAS1R3

IFI Score

213

Pathway Edits

  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • mGluR1 pathway primary gene cluster for umami (IFI-U) tri-axis component
  • TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent CUS pathway operation
  • Cross-pathway regulatory circuit for balanced CUS triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, mGluR1, and TAS1R2/TAS1R3 pathways simultaneously engineeredBalanced tri-axis expression strategy (CUS) with cross-pathway flux managementLNP-mediated delivery of triple-axis mRNA panel for transient expression profiling

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV CUS triple-axis construct for advanced multi-modal sensory architecture combining cooling, umami, and sweet axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$4249 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities